STOCK TITAN

Saba discloses 10.46% stake in Sharps Technology (STSS) update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Saba Capital Management and affiliates have filed an amended Schedule 13G reporting a significant passive stake in Sharps Technology, Inc. The filing shows that Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (together, the reporting persons) beneficially own 3,195,097 shares of Sharps Technology common stock and warrants, representing 10.46% of the class.

The percentage is calculated using 28,995,402 shares outstanding as of December 15, 2025, plus 1,538,462 shares issuable upon exercise of certain warrants held by the reporting persons. All 3,195,097 shares are reported with shared voting and shared dispositive power, and none with sole power. The funds and accounts advised by Saba Capital have the right to receive dividends and sale proceeds, and the reporting persons certify the securities are not held to change or influence control of Sharps Technology.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G




Comment for Type of Reporting Person: The denominator of the fraction upon which the percentages are calculated is based on (i) 28,995,402 Shares outstanding as of December 15, 2025 as reported on the Issuer's 424B3 filed with the Securities and Exchange Commission on January 13, 2026 plus (ii) 1,538,462 Shares issuable upon the exercise of certain warrants held by the Reporting Persons.


SCHEDULE 13G



Saba Capital Management, L.P.
Signature:/s/ Michael D'Angelo
Name/Title:General Counsel
Date:01/15/2026
Boaz R. Weinstein
Signature:/s/ Michael D'Angelo
Name/Title:Authorized Signatory
Date:01/15/2026
Saba Capital Management GP, LLC
Signature:/s/ Michael D'Angelo
Name/Title:Attorney-in-fact*
Date:01/15/2026

Comments accompanying signature: SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 15, 2026 /s/ Signature Michael D'Angelo Name: Michael D'Angelo Title: General Counsel Boaz R. Weinstein By: Michael D'Angelo Title: Attorney-in-fact*** *** Pursuant to a Power of Attorney dated as of November 16, 2015

FAQ

What ownership stake in Sharps Technology (STSS) does Saba report in this Schedule 13G/A?

The reporting persons disclose beneficial ownership of 3,195,097 shares of Sharps Technology common stock and warrants, representing 10.46% of the class.

Who are the reporting persons in the Sharps Technology (STSS) Schedule 13G/A filing?

The filing is made jointly by Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein as the reporting persons.

How was the 10.46% ownership in Sharps Technology (STSS) calculated?

The 10.46% is based on 28,995,402 shares outstanding as of December 15, 2025 plus 1,538,462 shares issuable upon exercise of warrants held by the reporting persons.

Does Saba have sole or shared voting power over Sharps Technology (STSS) shares?

The filing reports 0 shares with sole voting or dispositive power and 3,195,097 shares with shared voting and shared dispositive power for each reporting person.

Are Saba’s Sharps Technology (STSS) holdings intended to influence control of the company?

The certification states the securities were not acquired and are not held for the purpose or effect of changing or influencing control of Sharps Technology, other than activities solely in connection with a nomination under Rule 240.14a-11.

Who receives dividends and sale proceeds from the Sharps Technology (STSS) shares reported by Saba?

The filing explains that the funds and accounts advised by Saba Capital have the right to receive dividends and proceeds of sales from the common stock.
Sharps Tech

NASDAQ:STSS

View STSS Stock Overview

STSS Rankings

STSS Latest News

STSS Latest SEC Filings

STSS Stock Data

51.90M
26.85M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
MELVILLE